Due to the complexity of data collection, the most updated information at the National Cancer Registry refers to 2016 collected data, but is the most updated data currently available.
The incidence trends (number of new cases) in 1996 - 2016 show a distinct increase through the mid 2000's in all population groups (Jews, Arabs, "others"), followed by a distinct decrease. The incidence in "other" men were the highest and those of Arab men were the lowest throughout the entire period. These trends match the availability of the PSA test in Israel, starting in the 90's. In 2002, new instructions were published not to recommend this test for men age 75 and up, and in 2008, the recommendations were updated, advising to avoid taking the test as an elective screening until after hearing about the advantages and disadvantages of taking the test. The decrease indicated in prostate cancer incidence in Israeli men in recent years seems to reflect those changes as well.
As said, the Ministry of Health and ICA guidelines for early detection of cancer diseases do not include a sweeping recommendation for screening. However, the ICA does recommend paying attention to symptoms requiring medical attention. The main symptom requiring examination is difficulty in urinating. In addition, one or more of the following symptoms may occur: